Standout Papers
- Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer (2000)
- Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study (2011)
Immediate Impact
7 by Nobel laureates 3 from Science/Nature 87 standout
Citing Papers
Analysis of Breast Cancer Mortality in the US—1975 to 2019
2024 Standout
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2023 Standout
Works of P. Chollet being referenced
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
2011 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| P. Chollet | 5059 | 2554 | 1464 | 1587 | 241 | 8.4k | |
| G. Milano | 7643 | 1514 | 3057 | 3973 | 390 | 12.0k | |
| Antonio Russo | 5634 | 3159 | 2301 | 4657 | 368 | 11.6k | |
| Luigi Dogliotti | 4887 | 2187 | 2514 | 1818 | 197 | 11.0k | |
| Patrick J. Flynn | 6762 | 1532 | 2563 | 2177 | 144 | 10.9k | |
| Jesús García‐Foncillas | 3047 | 4116 | 1457 | 5907 | 309 | 10.2k | |
| Yasuo Miyoshi | 3302 | 2244 | 1023 | 4508 | 244 | 9.0k | |
| Masayuki Takeda | 3274 | 860 | 3111 | 2388 | 422 | 10.6k | |
| Mario Mandalà | 7021 | 924 | 1732 | 4695 | 266 | 11.4k | |
| Ron H.J. Mathijssen | 7051 | 1615 | 3420 | 5011 | 448 | 13.8k | |
| Youcef M. Rustum | 3668 | 1096 | 1285 | 3480 | 243 | 8.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...